Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

University of Wisconsin (UW)

Status: Completed

Conditions: Hepatitis C; Hepatic Fibrogenesis

Study type: Observational

Funder types: Other

Identifiers

NCT00205075

H-2004-0161

Details and patient eligibility

About

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Enrollment: 47 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately

Exclusion criteria

• HIV co-infection
• Treated within the past 6 months
• History (hx) of other liver disease
• Alcohol use greater than 30 g/day or history of binge drinking in the last year
• Decompensated liver disease

Trial design

47 participants in 2 patient groups

Case

Control